financetom
Business
financetom
/
Business
/
Cement demand likely to grow 8% in FY20, says Icra report
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cement demand likely to grow 8% in FY20, says Icra report
May 1, 2019 9:37 AM

The domestic cement demand is likely to grow by 8 percent this fiscal, which may push the capacity utilisation to 71 percent from 65 percent in FY18, the report said Wednesday.

The growth in demand will be driven by a likely 18-20 million tonnes per annum (MTPA) of additional production capacity during the fiscal.

The domestic cement production rose by around 13 percent between April 2018 and February 2019 as compared to six percent year-on-year growth in FY18, the rating agency Icra said in its report.

"For FY20, we expect a demand growth of eight percent and given the limited capacity addition, this is likely to result in an improvement in the industry's utilisation to 71 percent in FY20 from 65 percent in FY18. Improved capacity utilisation is likely to support the price uptick which has been seen since March 2019," Icra senior vice president Sabyasachi Majumdar said. He further said around 18-20 MTPA of capacity is likely to get added in FY20.

"However, a disproportionate part of the capacity addition is grinding opposed to clinker capacity. Thus, the actual production from new capacities could be lower. With the incremental demand of around 24-28 million tonne being greater than the incremental supply, this is likely to translate to improved capacity utilisation," Majumdar said.

Icra further noted that while in some regions such as north, north-east and east, the cement players' utilisation is likely to be higher than the national average, in other regions such as south and west, the utilisation is likely to remain muted given the past capacity overhang.

The agency pointed out that cement production remains healthy supported by the demand in south India, primarily in Andhra Pradesh and Telangana driven by irrigation, low-cost housing and infrastructure projects and Tamil Nadu is driven by infrastructure and rural housing.

Also, the strong growth in demand in eastern and western India, which is driven by low-cost housing and infrastructure demand, in the north led by the execution of infrastructure projects and in the central part of the country backed by rural housing, will boost cement production.

According to Icra, cement prices declined in most markets in FY19 in the range of 2.5-4.5 percent on a Y-o-Y basis. In the Delhi and Kolkata markets, the average cement price was lower by Rs 10 per bag in FY19 on a Y-o-Y basis at Rs 290 per bag and Rs 283 per bag, respectively. In Kolkata, the average price was lower by Rs 15 per bag at Rs 335 per bag in FY19.

The prices remained under pressure in August 2018 due to the monsoon, declining in most markets on a month-on-month basis. The prices were subdued during September 2018 February 2019.

"The continued focus on the housing sector and rural economy in the Union Budget for 2019-20 is likely to have a positive impact on the cement industry. On the infrastructure side, the continued thrust on the roads and railways is likely to push cement demand. While the healthy demand is likely to support the recent price increase, the supply side pressure on prices in some regions cannot be ruled out completely," Majumdar added.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nova Lifestyle's 2023 Net Loss Narrows, Net Sales Decline; Shares Rise
Nova Lifestyle's 2023 Net Loss Narrows, Net Sales Decline; Shares Rise
Apr 15, 2024
01:54 PM EDT, 04/15/2024 (MT Newswires) -- Nova Lifestyle ( NVFY ) reported a 2023 net loss from continuing operations Monday of $7.7 million, compared with a loss of $17.1 million a year earlier. Net sales for the year ended Dec. 31 were $11.1 million, down from $12.7 million a year earlier. Analyst estimates were not available. Shares of the...
Why Is Penny Stock Soligenix Trading Higher On Monday?
Why Is Penny Stock Soligenix Trading Higher On Monday?
Apr 15, 2024
On Monday, Soligenix Inc ( SNGX ) received an FDA orphan drug designation for the active ingredient in MarVax, the subunit protein vaccine of recombinantly expressed Marburg marburgvirus (MARV) glycoprotein, for the prevention and post-exposure prophylaxis against MARV infection. In addition to providing a seven-year term of market exclusivity upon final FDA approval, orphan drug designation also positions Soligenix ( SNGX ) to...
CleanSpark Is Holding Up Better Than Other Bitcoin Mining Stocks Monday: What's Going On?
CleanSpark Is Holding Up Better Than Other Bitcoin Mining Stocks Monday: What's Going On?
Apr 15, 2024
CleanSpark Inc ( CLSK ) shares are trading slightly higher Monday despite weakness across crypto markets. Here’s a look at what’s going on. What To Know: Several crypto-related stocks are trading lower Monday as Bitcoin (CRYPTO: BTC) and the broader crypto market continue to move lower, pulling back following recent strength in the wake of the approval of spot bitcoin...
Eagle Pharmaceuticals Says Phase 3 Data Show Amisulpride's Sustained Antiemetic Effect; Shares Rise
Eagle Pharmaceuticals Says Phase 3 Data Show Amisulpride's Sustained Antiemetic Effect; Shares Rise
Apr 15, 2024
01:49 PM EDT, 04/15/2024 (MT Newswires) -- Eagle Pharmaceuticals ( EGRX ) shares climbed 9% in recent trading after the company said Monday that it will present phase III trial data showing that intravenous amisulpride may sustain an antiemetic effect in adult surgical patients with moderate to high risk of postoperative nausea and vomiting. The data relate to a subset...
Copyright 2023-2026 - www.financetom.com All Rights Reserved